G

Genomed SA
WSE:GEN

Watchlist Manager
Genomed SA
WSE:GEN
Watchlist
Price: 25.4 PLN Market Closed
Market Cap: 33.5m PLN
Have any thoughts about
Genomed SA?
Write Note

Wall Street
Price Targets

GEN Price Targets Summary
Genomed SA

There are no price targets for GEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomed SA Competitors:
Price Targets
INCY
Incyte Corp
15% Upside
HALO
Halozyme Therapeutics Inc
39% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
30% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
23% Upside
ACLX
Arcellx Inc
55% Upside
ACHV
Achieve Life Sciences Inc
355% Upside
MGX
Metagenomi Inc
368% Upside

Revenue
Forecast

Revenue Estimate
Genomed SA

Revenue forecast
is not available for
Genomed SA

Operating Income
Forecast

Operating Income Estimate
Genomed SA

Operating Income forecast
is not available for
Genomed SA

Net Income
Forecast

Net Income Estimate
Genomed SA

Net Income forecast
is not available for
Genomed SA

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GEN's stock price target?
Not Available

GEN doesn't have any price targets made by Wall Street professionals.

Back to Top